The role of specialist nurses in detecting spasticity and related symptoms in multiple sclerosis

被引：2

作者：

Artola, Montse ^{[1
]}

Hernando, Ana ^{[1
]}

Vidal, Oscar ^{[2
]}

Vidal, Nuria ^{[3
]}

Cuenca, Ester ^{[4
]}

Horno, Rosalia ^{[5
]}

Robles, Miguel Angel ^{[5
]}

Oriol, Clara ^{[5
]}

Peralta, Silvia ^{[6
]}

Solana, M. A. Jose ^{[6
]}

Rubio, Matilde ^{[7
]}

Montero, Cristina ^{[7
]}

Lleixa, Merce ^{[8
]}

Zabay, Cinta ^{[9
]}

Martin, Montse ^{[10
]}

Leon, Isabel ^{[11
]}

Molinos, Consuelo ^{[12
]}

Matamoros, Mandi ^{[13
]}

Mercade, Laura ^{[14
]}

Fornali, Olga ^{[15
]}

Montero, Laura ^{[16
]}

Saiz, Albert ^{[1
]}

Sola-Valls, Nuria ^{[17
]}

机构：

[1] Univ Barcelona, Inst Invest Biomed August Pi Sunyer IDIBAPS, Hosp Clin Barcelona, Unidad Neuroinmunol Esclerosis multiple, Barcelona, Spain

[2] Hosp Univ Mutua Terrassa, Barcelona, Spain

[3] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[4] Hosp Residencia Sant Camil, Barcelona, Spain

[5] Hosp Univ Vall Hebron, Ctr Esclerosi Multiple Catalunya, Barcelona, Spain

[6] Hosp Arnau Vilanova, Lleida, Spain

[7] Hosp Figueres, Fundacio Salut Emporda, Girona, Spain

[8] Hosp Sant Joan Despi Moises Broggi, Barcelona, Spain

[9] Fundacio Esclerosi Multiple, Ctr Neurorehabilitador Mas Sabate, Reus, Spain

[10] Hosp Sant Joan Deu Althaia Manresa, Barcelona, Spain

[11] Hosp Univ Bellvitge, Barcelona, Spain

[12] Hosp Badalona Germans Trias & Pujol, Badalona, Spain

[13] Hosp Verge Cinta Tortosa, Tarragona, Spain

[14] Hosp Vendrell, Tarragona, Spain

[15] Hosp Del Mar, Barcelona, Spain

[16] Consorci Hosp Vic, Barcelona, Spain

[17] Hosp Univ Sant Joan Reus, Inst Invest Sanitaria Pere Virgili IISPV, Secc Neurol, Reus, Spain

来源：

JOURNAL OF CLINICAL NURSING | 2023年 / 32卷 / 13-14期

关键词：

limiting symptoms; multiple sclerosis; quality of life; spasticity; specialist nurses; IMPAIRMENT; MANAGEMENT; GAIT;

D O I：

10.1111/jocn.16421

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

Background Spasticity is a frequent symptom of multiple sclerosis (MS), which may negatively influence daily living activities (ADL). Objectives To (1) explore the feasibility to conduct a structured interview by specialist nurses about limitations in ADL; (2) determine the percentage of people with MS (PwMS) with limitations in ADL related to spasticity; (3) to assess the knowledge about spasticity and describe its clinical features. Design Observational, cross-sectional, multicentre study in 16 MS units of Catalonia (Spain). Participants were recruited from the outpatient facility and day-care hospital between July 2018 and June 2019 and met the following criteria: (1) age 18 or older, (2) diagnosis of MS according to McDonald criteria 2010 and (3) no clinical relapse in previous 30 days. Methods Specialist nurses conducted a structured interview divided in two parts: the assessment of (1) limitations in the ADL and (2) the presence of spasticity and associated symptoms. The usefulness of this intervention was requested. This study met the STROBE reporting guidelines checklist for observational studies. Results Three hundred sixty eight pwMS (244 women) with a mean age of 46 years and a median Expanded Disability Status Scale score of 2.5 (range, 0-8.5) were included. 262 (71%) pwMS had limitations in the ADL, and spasticity was reported as the most limiting symptom in 59 (23%). As a result of the interview, spasticity was observed in 199 (76%) participants; 47 (24%) of them were unaware that they had spasticity and 102 (51%) would not have reported it spontaneously. The level of the interview satisfaction was high (90%). Conclusions Spasticity is a complex and limiting symptom in MS. The structured interview conducted by specialist nurses is feasible and has good acceptance. Patient contribution Specialist nurses can be proactive in MS clinical assessment, which may help to detect symptoms with negative impact on quality of life.

引用

页码：3496 / 3503

页数：8

共 50 条

[1] Multiple Sclerosis, Neuromyelitis Optica and Spasticity: Control of Specific Symptoms and Quality of Life
Patejdl, R.
Tesar, S.
Zettl, U. K.
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2014, 82 (07) : 373 - 385
[2] Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience
Sammaraiee, Yezen
Yardley, Martin
Keenan, Liz
Buchanan, Katrina
Stevenson, Val
Farrell, Rachel
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 95 - 100
[3] Persistence with Botulinum Toxin Treatment for Spasticity Symptoms in Multiple Sclerosis
Novarella, Federica
Carotenuto, Antonio
Cipullo, Paolo
Iodice, Rosa
Cassano, Emanuele
Spiezia, Antonio Luca
Capasso, Nicola
Petracca, Maria
Falco, Fabrizia
Iacovazzo, Carmine
Servillo, Giuseppe
Lanzillo, Roberta
Morra, Vincenzo Brescia
Moccia, Marcello
TOXINS, 2022, 14 (11)
[4] Spasticity in multiple sclerosis and role of glatiramer acetate treatment
Eustasio Meca-Lallana, Jose
Hernandez-Clares, Rocio
Carreon-Guarnizo, Ester
BRAIN AND BEHAVIOR, 2015, 5 (09):
[5] The role of specialist and general nurses working with people with multiple sclerosis
While, Alison
Forbes, Angus
Ullman, Roz
Mathes, Lucia
JOURNAL OF CLINICAL NURSING, 2009, 18 (18) : 2635 - 2648
[6] Spasticity and everyday life in multiple sclerosis
Donze, C.
De Seze, J.
REVUE NEUROLOGIQUE, 2012, 168 : S51 - S56
[7] Advances in the management of multiple sclerosis symptoms: pathophysiology and assessment of spasticity in multiple sclerosis
Tintore, Mar
NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (06) : 15 - 17
[8] Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis
Meuth, Sven G.
Vila, Carlos
Dechant, Kerry L.
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (08) : 909 - 918
[9] Effectiveness, Safety and Patients' Satisfaction of Nabiximols (Sativex®) on Multiple Sclerosis Spasticity and Related Symptoms in a Swiss Multicenter Study
Sacco, Rosaria
Riccitelli, Gianna Carla
Disanto, Giulio
Bogousslavsky, Julien
Cavelti, Ariane
Czell, David
Kamm, Christian Philipp
Kliesch, Uta
Ramseier, Simon Peter
Gobbi, Claudio
Zecca, Chiara
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
[10] A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis
Arroyo Gonzalez, Rafael
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2018, 18 (10) : 785 - 791

← 1 2 3 4 5 →